Lung Cancers Completed Phase 2 Trials for Tipifarnib (DB04960)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Completed2 IdentifierTitlePurposeDrugs
NCT00005989R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung CancerTreatment
NCT00005041R115777 in Treating Patients With Relapsed Small Cell Lung CancerTreatment